Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients

بواسطة Wang, L.-Z., Ramírez, J., Yeo, W., Chan, M.-Y.M., Thuya, W.-L., Lau, J.-Y.A., Wan, S.-C., Wong, A.L.-A., Zee, Y.-K., Lim, R., Lee, S.-C., Ho, P.C., Lee, H.-S., Chan, A., Ansher, S., Ratain, M.J., Goh, B.-C.
منشور في 2014